{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:12:09Z","timestamp":1793747529842,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ophtha.2014.03.016","type":"journal-article","created":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T14:45:16Z","timestamp":1398523516000},"page":"1677-1682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["High-Dose Subconjunctival Cyclosporine A Implants Do Not Affect Corneal Neovascularization after High-Risk Keratoplasty"],"prefix":"10.1016","volume":"121","clinical-trial-number":[{"clinical-trial-number":"nct00447187","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Felix","family":"Bock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Matthaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"B\u00f6hringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Christoph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ganslandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2014.03.016_bib1","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(94)31138-9","article-title":"Risk factors for corneal graft failure and rejection in the Collaborative Corneal Transplantation studies","volume":"101","author":"Maguire","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.03.016_bib2","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","article-title":"Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis","volume":"117","author":"Bachmann","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.03.016_bib3","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","article-title":"Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2014.03.016_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archopht.126.1.71","article-title":"Promotion of graft survival by vascular endothelial growth factor A neutralization after high-risk corneal transplantation","volume":"126","author":"Bachmann","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0002-9394(01)01426-X","article-title":"Immunologic graft reactions after allogenic penetrating keratoplasty","volume":"133","author":"Jonas","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib6","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis","volume":"48","author":"Bock","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2014.03.016_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1755-3768.2012.02525.x","article-title":"Topical ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis","volume":"92","author":"Bucher","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib8","first-page":"2148","article-title":"Fine needle diathermy occlusion of corneal vessels","volume":"41","author":"Pillai","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2014.03.016_bib9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/ICO.0b013e31823f8f7a","article-title":"Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs","volume":"31","author":"Koenig","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2014.03.016_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archophthalmol.2011.42","article-title":"Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids","volume":"129","author":"Hos","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib11","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ophtha.2009.04.016","article-title":"GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial","volume":"116","author":"Cursiefen","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.03.016_bib12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ophtha.2011.01.041","article-title":"Horizons in therapy for corneal angiogenesis","volume":"118","author":"Maddula","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.03.016_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.preteyeres.2013.01.001","article-title":"Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases","volume":"34","author":"Bock","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ophtha.2014.03.016_bib14","first-page":"2127","article-title":"Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin","volume":"43","author":"Cursiefen","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2014.03.016_bib15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4049\/jimmunol.0903180","article-title":"Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation","volume":"184","author":"Dietrich","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib16","first-page":"274","article-title":"Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A","volume":"38","author":"Benelli","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2014.03.016_bib17","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/archderm.1989.01670220055007","article-title":"Cyclosporine inhibits basic fibroblast growth factor-driven proliferation of human endothelial cells and keratinocytes","volume":"125","author":"Sharpe","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archopht.1992.01080150103037","article-title":"Suppression of corneal neovascularization with cyclosporine","volume":"110","author":"Lipman","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.193.5.607","article-title":"Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2","volume":"193","author":"Hernandez","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ophtha.2014.03.016_bib20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0161-6420(93)31558-7","article-title":"Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye","volume":"100","author":"Milani","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.03.016_bib21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.TP.0000158022.62059.F2","article-title":"Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study","volume":"79","author":"Birnbaum","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.ophtha.2014.03.016_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s004170100285","article-title":"Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial","volume":"239","author":"Reinhard","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003226-199911000-00003","article-title":"Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A","volume":"18","author":"Reinhard","year":"1999","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2014.03.016_bib24","first-page":"81","article-title":"Topical cyclosporin stimulates neovascularization in resolving sterile rheumatoid central corneal ulcers","volume":"98","author":"Gottsch","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2014.03.016_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajo.2011.01.019","article-title":"Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation","volume":"152","author":"Shimazaki","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib26","first-page":"189","article-title":"Cyclosporin-A and its metabolites in the anterior chamber after topical and systemic application as determined with high-performance liquid chromatography-electrospray mass spectrometry","volume":"5","author":"Althaus","year":"1996","journal-title":"Ger J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib27","first-page":"1461","article-title":"Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats","volume":"12","author":"Bourges","year":"2006","journal-title":"Mol Vis [serial online]"},{"key":"10.1016\/j.ophtha.2014.03.016_bib28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1160\/ME9060","article-title":"Experiences with an interoperable data acquisition platform for multi-centric research networks based on HL7 CDA","volume":"46","author":"Klein","year":"2007","journal-title":"Methods Inf Med"},{"key":"10.1016\/j.ophtha.2014.03.016_bib29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s004170100313","article-title":"Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty","volume":"239","author":"Cursiefen","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ajo.2005.08.080","article-title":"Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty","volume":"141","author":"Lam","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib31","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1167\/iovs.06-0985","article-title":"A\u00a0pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection","volume":"48","author":"Lee","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2014.03.016_bib32","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00003226-200210000-00003","article-title":"Corneal neovascularization after nonmechanical versus mechanical corneal trephination for non-high-risk keratoplasty","volume":"21","author":"Cursiefen","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2014.03.016_bib33","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"Cursiefen","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ophtha.2014.03.016_bib34","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/bjo.2008.145128","article-title":"Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation","volume":"93","author":"Bachmann","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bjo.2011.204701","article-title":"Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable","volume":"96","author":"Cursiefen","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajo.2007.03.028","article-title":"Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty","volume":"144","author":"Nguyen","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.03.016_bib37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ophtha.2011.10.016","article-title":"Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial","volume":"119","author":"Shimazaki","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.03.016_bib38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ophtha.2012.09.035","article-title":"A\u00a0novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study","volume":"120","author":"Shi","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.03.016_bib39","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","article-title":"Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision","volume":"103","author":"Cursiefen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014002401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014002401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:04:49Z","timestamp":1758981889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642014002401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0161642014002401"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.03.016","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Dose Subconjunctival Cyclosporine A Implants Do Not Affect Corneal Neovascularization after High-Risk Keratoplasty","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}